Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
종목 코드 PLRZ
회사 이름Polyrizon Ltd
상장일Oct 29, 2024
CEOMr. Tomer Izraeli
직원 수1
유형Ordinary Share
회계 연도 종료Oct 29
주소HaTidhar St. 5
도시RA'ANANA
증권 거래소NASDAQ Capital Market Consolidated
국가Israel
우편 번호- -
전화97293740120
웹사이트https://polyrizon-biotech.com/
종목 코드 PLRZ
상장일Oct 29, 2024
CEOMr. Tomer Izraeli
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음